EUVIMEDEUVIMED entdecken
Crossref

Innovative Drug Delivery Systems for Neurological Disorders: Pharmaceutical Design, Neuropharmacology, and Clinical Implications

Dr. Animesh Dey, Ayushi Singh, Dr. Srinivasa K, Monica MM, Rashmi HR, Dr. Seema Yadav

International Journal of Drug Delivery Technology · 10.04.2026 · 16 (16s)

DOI: 10.25258/ijddt.16.16s.35 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 10.04.2026. Verfasst von Dr. Animesh Dey und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurological diseases are an emergent health issue in the world, but effective treatment is hampered by the limited exposure of the brain, systemic toxicity, and the physiological limitation of the blood to the brain barrier (BBB). This review discusses the potential of neuropharmacological principles and pharmaceutical design methods (i.e. physicochemical optimization, prodrug and molecular modification, and formulation engineering) to increase CNS targeting and therapeutic efficacy. Current advances in drug delivery technologies are discussed, including nanotechnology-based platforms (polymeric, lipid-based, and inorganic/hybrid nanocarriers), biological and biomimetic systems (extracellular vesicles, cell-mediated delivery, and peptide/protein targeting), and non-invasive administration routes such as intranasal and microneedle-assisted delivery. Smart and advanced platforms, including stimuli-responsive systems, nucleic acid delivery vectors, multifunctional theranostic designs, and artificial intelligence–assisted formulation development, are highlighted as emerging strategies to improve spatial and temporal control of drug release. Clinical relevance is evaluated across neurodegenerative, neuropsychiatric, cerebrovascular, and neuro-oncological disorders, with emphasis on the increasing role of biomarkers and imaging endpoints in linking delivery performance to therapeutic outcomes. The main challenges of translation, such as lack of predictability of preclinical models over time, long-term safety, the complexity of regulations, and scalability of manufacturing are addressed in the framework of the clinical impact acceleration.

Zitieren

APA

Dey, D. A., Singh, A., K, D. S., MM, M., HR, R., & Yadav, D. S. (2026). Innovative Drug Delivery Systems for Neurological Disorders: Pharmaceutical Design, Neuropharmacology, and Clinical Implications. International Journal of Drug Delivery Technology, 16(16s). https://doi.org/10.25258/ijddt.16.16s.35

Vancouver

Dey DA, Singh A, K DS, MM M, HR R, Yadav DS. Innovative Drug Delivery Systems for Neurological Disorders: Pharmaceutical Design, Neuropharmacology, and Clinical Implications. International Journal of Drug Delivery Technology. 2026;16(16s). doi:10.25258/ijddt.16.16s.35

BibTeX
@article{Dey2026,
  author = {Dey, Dr. Animesh and Singh, Ayushi and K, Dr. Srinivasa and MM, Monica and HR, Rashmi and Yadav, Dr. Seema},
  title = {Innovative Drug Delivery Systems for Neurological Disorders: Pharmaceutical Design, Neuropharmacology, and Clinical Implications},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {16s},
  doi = {10.25258/ijddt.16.16s.35}
}
Kostenlos starten →